Information for "Atezolizumab in in your area innovative or perhaps metastatic urothelial cancer malignancy a combined analysis from the Speaking spanish individuals from the IMvigor 210 cohort 2 as well as 211 reports"
From EECH Central
Basic information
| Display title | Atezolizumab in in your area innovative or perhaps metastatic urothelial cancer malignancy a combined analysis from the Speaking spanish individuals from the IMvigor 210 cohort 2 as well as 211 reports |
| Default sort key | Atezolizumab in in your area innovative or perhaps metastatic urothelial cancer malignancy a combined analysis from the Speaking spanish individuals from the IMvigor 210 cohort 2 as well as 211 reports |
| Page length (in bytes) | 3,412 |
| Page ID | 1311360 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
Page protection
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
Edit history
| Page creator | Pricedaisy83 (Talk | contribs) |
| Date of page creation | 09:01, 28 March 2024 |
| Latest editor | Pricedaisy83 (Talk | contribs) |
| Date of latest edit | 09:01, 28 March 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 1 |
| Recent number of distinct authors | 1 |
